ArticleSAGE open medical case reports2023

Dual first-line maintenance by PARP inhibitor and bevacizumab can cause confusion in high-grade serous ovarian cancer: A case of PRES and a review of the literature.

Aikaterini Liapi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.